Trade Tracker: Jim Lebenthal buys more Abbvie
0
0
11/11/24
Dans
Amérique du Nord / États-Unis
Jim Lebenthal, chief equity strategist at Cerity Partners, joins CNBC's 'Halftime Report' to discuss why he's buying more of the pharma stock on this dip.
Montre plus
0 commentaires
sort Trier par
